Troy A. Ignelzi, Chief Financial Officer at Karuna Therapeutics, Inc. (KRTX), sold 7,200 shares at $110.07 ($794K) on 2021-05-10, disclosed to the SEC on 2021-05-12.
Open-market sale of $794k KRTX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $110.07 | 7,000 | $770K | 97.0% |
| 2 | $120.00 | 200 | $24K | 3.0% |
| Total | $110.35 avg | 7,200 | $794K | 100% |
| Filing → |
| KRTX | SELL | 2023-05-25 | $4.0M | — | Filing → |
| KRTX | SELL | 2023-02-23 | $1.1M | — | Filing → |
| KRTX | SELL | 2023-01-19 | $369K | — | Filing → |